WHO Finds that Gilead’s Remdesivir has ‘little or no effect’ on COVID-19 recovery or mortality Nevertheless, Gilead expects to make $3.5 billion from Remdesivir this year https://www.fiercepharma.com/pharma/gilead-s-remdesivir-has-little-or-n… Study Finds Positive association between COVID-19 deaths and influenza vaccination rates in elderly people worldwide https://peerj.com/articles/10112/
The post Remdesivir and Flu Vaccinations not solutions to Covid Threat appeared first on PaulCraigRoberts.org.
Source